SpaceX Falling to $100: A Clear Line in The Sand
SpaceX has shed more than a third of its value in weeks, and every options desk, prediction market, and Reddit thread has locked onto the same number as the moment of truth. Whether institutional…
Investing
All Investing Articles
Newest first · Page 252
Laid Off at 63 Means Retired, Ready or Not. These 4 ETFs Turn Your Severance Into a Salary
A Tuesday phone call ended 26 years of steady paychecks, and now a severance check sits on the kitchen table with no real retirement plan behind it. Four income ETFs can turn that lump…
The VIX Bet Behind SVOL: How a 0.66% Fee Masks the Real Cost of Short Volatility
SVOL's 20% monthly yield sounds like a dream until you look at what the fund quietly hands back to investors, who is already running for the exits, and what happens to your principal when…
You Sold the Big House and Banked $300K. These 3 ETFs Turn the Windfall Into a Monthly Check
Selling the big house left you with a six-figure windfall and no mortgage, but a savings account will quietly lose the battle against inflation. Three funds built around very different strategies could turn that…
From $100 to $2,021 in Five Years: How Daily-Reset Leverage Turns Trends Into Fortunes
A leveraged ETF promising twice NVIDIA's daily returns is somehow trailing the stock it tracks, yet a single $100 bet placed five years ago ballooned into something extraordinary. The math behind that contradiction will…
$10,000 in AMDL Became $40,270 in 7 Months, but AMD’s Earnings Crash Erased $9,500 in One Day
A leveraged AMD fund turned a modest stake into a small fortune over seven months, then a single earnings report wiped out nearly a quarter of those gains in hours. Here is what the…
Jim Cramer: SpaceX Could Reach $1 Trillion in Revenue by 2030, but “Short Term, Forget About It”
Jim Cramer just called SpaceX a trillion-dollar business while warning investors to brace for a brutal stretch ahead, and the reason behind that contradiction comes down to one date on the calendar.
Bitcoin Is Down 44%, and BlackRock Just Launched a Fund That Pays You to Wait
Bitcoin has spent a year punishing patient holders with nothing but losses and silence. BlackRock just launched a fund that flips that equation, and the structure of the trade reveals something most IBIT investors…
How ProShares Ultra QQQ Quietly Built $14.46 Billion in Assets Despite Warnings That Leveraged ETFs Destroy Long-Term Wealth
Financial advisors warn that leveraged ETFs will erode your wealth over time, yet one 2x Nasdaq fund has quietly grown to nearly $15 billion in assets. The story of how that happened reveals something…
Utilities Are Up 8% on AI Power Demand. The Fund Actually Building the Data Centers Is Up 40%
Utility stocks are riding the AI power wave, but the companies actually bolting together the data centers are running a very different race. Knowing which fund owns which part of the chain could change…
Live: Will MercadoLibre Crush Q2 Earnings Tonight After the Bell?
MercadoLibre posts Q2 results tonight with revenue accelerating past 40% growth while earnings estimates have been slashed, putting management on a collision course with skeptical investors hungry for proof that the spending binge is…
Live: Will AppLovin Crush Q2 Earnings Tonight After the Market Closes?
AppLovin has beaten earnings four straight quarters, yet the stock sits nearly 38% below its yearly highs as Q2 results hit after the close tonight. Will another beat finally reverse the slide, or has…
Elon Musk Predicts ‘Money Won’t Matter in 2036.’ Is This His Worst Prediction Yet or Prophetic?
Elon Musk told a crowd at Tesla's Texas Gigafactory that currency itself will become pointless within a decade, and economists are lining up on both sides of whether that claim deserves serious analysis or…
Live: Will SanDisk Smash Tonight’s Q4 Earnings After 500% YTD Rally?
SanDisk enters tonight's Q4 report carrying a 500% year-to-date gain, prediction markets near certainty on a beat, and a stock that somehow dropped after its last blowout quarter. Find out whether the results matched…
Eli Lilly’s Weight-Loss Drug Demand Is Nearly Limitless. Here’s What Comes Next for the $1 Trillion Drugmaker
Eli Lilly just posted numbers that stunned Wall Street, but the company's own executives admit a single bottleneck could cap how far the GLP-1 juggernaut actually runs, and the next move to break through…